Business & Industry

BioNTech and Gilead Partner for Pumitamig Clinical Trial

Yuvraj — Fri, 23 Oct 2026 13:03:30 +0000

BioNTech SE has officially entered into a clinical trial collaboration and supply agreement with Gilead Sciences Inc. to evaluate the bispecific immunomodulator pumitamig in combination with the TROP2-directed antibody-drug conjugate (ADC) sacituzumab govitecan. Announced on October 22, 2026, this strategic partnership aims to improve therapeutic outcomes for patients diagnosed with locally advanced or metastatic triple-negative […]

The post BioNTech and Gilead Partner for Pumitamig Clinical Trial first appeared on World Pharma Today.

Cencora to Acquire American Oncology Network in $2.4 Billion Deal

Yuvraj — Fri, 23 Oct 2026 12:38:52 +0000

Cencora has signed a definitive agreement to acquire American Oncology Network, a physician-led network of more than 350 oncology providers operating across 21 states, in a transaction that values AON at approximately $2.4 billion. The deal is set to expand Cencora’s physician-led oncology management services organization platform and extend its geographic presence into 12 additional […]

The post Cencora to Acquire American Oncology Network in $2.4 Billion Deal first appeared on World Pharma Today.

Merck Acquires Silence Therapeutics for $1.3 Billion

Yuvraj — Thu, 22 Oct 2026 05:11:51 +0000

Merck KGaA has entered into an agreement to acquire British biotech Silence Therapeutics for $1.3 billion in a fully cash-based transaction, securing the German pharmaceutical company’s access to a compelling short interfering RNA (siRNA) drug development platform and a late-stage candidate targeting a rare blood cancer. The deal values Silence at $20 per American depositary […]

The post Merck Acquires Silence Therapeutics for $1.3 Billion first appeared on World Pharma Today.

METiS TechBio and Eli Lilly Join Forces for Next-Generation Tissue-Specific LNP Delivery Technologies

Yuvraj — Wed, 21 Oct 2026 13:15:14 +0000

METiS TechBio has announced a strategic collaboration with Eli Lilly and Company to research and develop next-generation lipid nanoparticle (LNP)-based delivery solutions, leveraging METiS’s proprietary AI-driven platform to enable precise, tissue-specific delivery of therapeutic modalities. Under the terms of the agreement, METiS is eligible to receive an upfront payment in the low double-digit millions of […]

The post METiS TechBio and Eli Lilly Join Forces for Next-Generation Tissue-Specific LNP Delivery Technologies first appeared on World Pharma Today.

Eli Lilly and Mubadala Bio Sign Abu Dhabi GLP-1 Packaging Agreement

Yuvraj — Wed, 21 Oct 2026 13:10:55 +0000

Eli Lilly and Mubadala Bio have signed a formal agreement to develop local pharmaceutical packaging and logistics capabilities for Lilly’s GLP-1 medicines in Abu Dhabi, with the collaboration anchored by a dedicated 125,000 sqm site at Khalifa Economic Zones Abu Dhabi (KEZAD). A New Chapter for Abu Dhabi Pharmaceutical Capabilities The agreement was announced at […]

The post Eli Lilly and Mubadala Bio Sign Abu Dhabi GLP-1 Packaging Agreement first appeared on World Pharma Today.

Billerud Introduces New Pharmaceutical Packaging Option

Yuvraj — Fri, 16 Oct 2026 13:17:20 +0000

Billerud has officially introduced PharmaKraft, a specialized fibre-based packaging material carefully designed for non-sterile dry pharmaceutical applications. This newly developed product utilizes fresh fibre featuring tightly controlled purity characteristics to meet rigorous industry demands. As a notable addition to the market, this offering provides a reliable pharmaceutical packaging option for companies requiring high-quality material solutions. […]

The post Billerud Introduces New Pharmaceutical Packaging Option first appeared on World Pharma Today.

AstraZeneca Advances AI Drug Discovery Deal with insitro

Yuvraj — Fri, 16 Oct 2026 13:04:32 +0000

AstraZeneca has inked a billion-dollar AI drug discovery partnership and licensing deal with insitro to identify novel targets and therapies for a range of cardiometabolic diseases. Through this strategic agreement, the organizations will work in tandem to create drugs that fulfil unmet needs and address the underlying drivers of disease in both metabolic dysfunction-associated steatohepatitis […]

The post AstraZeneca Advances AI Drug Discovery Deal with insitro first appeared on World Pharma Today.

Danaher Prepares to Introduce Advanced AI-Powered Laboratory

Yuvraj — Thu, 08 Oct 2026 13:36:21 +0000

In a significant step for pharmaceutical research, Danaher has announced plans to launch its first AI-powered autonomous research facility. Expected to become fully operational in early 2027 at the Abcam headquarters in Cambridge, UK, the upcoming AI autonomous lab will combine robotics, artificial intelligence, and proprietary technologies into a single, unified workflow. This closed-loop system […]

The post Danaher Prepares to Introduce Advanced AI-Powered Laboratory first appeared on World Pharma Today.

$1.8 Billion Commitment to Centralize Biological Data

Yuvraj — Thu, 08 Oct 2026 13:28:21 +0000

The United States government, alongside technology enterprises Meta Platforms and Alphabet, is officially joining forces with the nonprofit organization Biohub. This collaborative effort aims to construct comprehensive open datasets designed to train advanced AI models for biological research, elevating the total investment in this initiative to $1.8 billion. Financial Contributions and Strategic Partnerships In a […]

The post $1.8 Billion Commitment to Centralize Biological Data first appeared on World Pharma Today.

India’s ₹2,333 Crore Weight-Loss Drug Story: Mounjaro, Semaglutide and the Next Phase of Competition

Yuvraj — Mon, 05 Oct 2026 11:45:55 +0000

India’s weight-loss drug story has moved well beyond a niche pharmaceutical category. GLP-1 medicines are now creating a rapidly expanding business around obesity and metabolic health, with Mounjaro and semaglutide at the centre of the competition. India’s GLP-1 segment reached ₹2,333 crore in sales for the 12 months ended August 2026. Unit sales grew 74% […]

The post India’s ₹2,333 Crore Weight-Loss Drug Story: Mounjaro, Semaglutide and the Next Phase of Competition first appeared on World Pharma Today.